Patent Yard Sign in
Canadian application, no grantCanada

Removal of tissue

CA 2065386 A1 · Owner: Anis, Aziz Yehia · Inventors: Anis, Aziz Yehia

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

To reduce damage to surrounding tissue while fragmenting some tissue, for example, not damaging the capsular wall while removing the lens during cataract removal surgery or not damaging artery or vein walls during bypass surgery while freeing the artery or vein to be transplanted, an incision is made for the insertion of a surface - discriminating, rotating, fragmenting tool (10) with blade portion (14). The blade portion (14) includes blades (17A and 17B) each of which is fastened to rotatable tubular shaft (18). The tool (10) fragments and permits aspiration of the tissue without damaging the surrounding wall by fragmenting surfaces of higher inertia material but moving at a rate of …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 15, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 15, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 15, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 15, 1991
GrantedNo grant recorded
Term endedJuly 15, 2011
Patent numberCA 2065386 A1
Classification (IPC)A61B17/32 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedJuly 15, 1991Term endedJuly 15, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.